1. Home
  2. INVX vs AUPH Comparison

INVX vs AUPH Comparison

Compare INVX & AUPH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INVX
  • AUPH
  • Stock Information
  • Founded
  • INVX 2024
  • AUPH 1993
  • Country
  • INVX United States
  • AUPH Canada
  • Employees
  • INVX N/A
  • AUPH N/A
  • Industry
  • INVX
  • AUPH Biotechnology: Pharmaceutical Preparations
  • Sector
  • INVX
  • AUPH Health Care
  • Exchange
  • INVX NYSE
  • AUPH Nasdaq
  • Market Cap
  • INVX 954.4M
  • AUPH 1.0B
  • IPO Year
  • INVX N/A
  • AUPH 1999
  • Fundamental
  • Price
  • INVX $17.37
  • AUPH $8.77
  • Analyst Decision
  • INVX
  • AUPH Strong Buy
  • Analyst Count
  • INVX 0
  • AUPH 3
  • Target Price
  • INVX N/A
  • AUPH $10.33
  • AVG Volume (30 Days)
  • INVX 420.7K
  • AUPH 1.4M
  • Earning Date
  • INVX 11-07-2024
  • AUPH 11-07-2024
  • Dividend Yield
  • INVX N/A
  • AUPH N/A
  • EPS Growth
  • INVX 175.29
  • AUPH N/A
  • EPS
  • INVX 6.87
  • AUPH N/A
  • Revenue
  • INVX $543,306,000.00
  • AUPH $220,361,000.00
  • Revenue This Year
  • INVX N/A
  • AUPH $36.52
  • Revenue Next Year
  • INVX $7.55
  • AUPH $19.02
  • P/E Ratio
  • INVX $2.46
  • AUPH N/A
  • Revenue Growth
  • INVX N/A
  • AUPH 38.72
  • 52 Week Low
  • INVX $13.80
  • AUPH $4.71
  • 52 Week High
  • INVX $25.19
  • AUPH $9.74
  • Technical
  • Relative Strength Index (RSI)
  • INVX N/A
  • AUPH 71.82
  • Support Level
  • INVX N/A
  • AUPH $7.87
  • Resistance Level
  • INVX N/A
  • AUPH $8.70
  • Average True Range (ATR)
  • INVX 0.00
  • AUPH 0.38
  • MACD
  • INVX 0.00
  • AUPH 0.04
  • Stochastic Oscillator
  • INVX 0.00
  • AUPH 96.67

About INVX INNOVEX INTERNATIONAL INC

Innovex International Inc designs, manufactures, and installs mission-critical drilling & deployment, well construction, completion, production, and fishing & intervention solutions to support upstream onshore and offshore activities worldwide. Its comprehensive portfolio extends throughout the lifecycle of the well; and innovative product integration ensures seamless transitions from one well phase to the next, driving efficiency, lowering cost, and reducing the rig site service footprint for the customer. With locations throughout North America, Latin America, Europe, the Middle East, and Asia, The team is readily available with technical expertise, conventional and innovative technologies, and ever-present customer service.

About AUPH Aurinia Pharmaceuticals Inc

Aurinia Pharmaceuticals Inc is a biopharmaceutical company. It provides products for patients suffering from serious diseases with a high unmet medical need. The firm is developing LUPKYNIS (voclosporin), an investigational drug, for the treatment of lupus nephritis (LN), and others. Geographically, it derives maximum revenue from the United States.

Share on Social Networks: